In this episode of the BroadEYE Podcast, Dr. Bruno Fernandes is joined by special guest co-host Dr. Carlos Quezada-Ruiz to welcome a titan in the field of ophthalmology: Dr. Rishi Singh. Dr. Singh was recently appointed as the Chair of Ophthalmology at Harvard Medical School and Mass Eye and Ear, as well as the Chair of the Integrated Department of Ophthalmology at Mass General Brigham. A physician-scientist with over 300 peer-reviewed publications, he brings a unique blend of frontline clinical expertise in retina and high-level health system leadership. Joining the podcast just 42 days into his new tenure, Dr. Singh opens …

Leadership, AI, and the Future of Retina with Dr. Rishi Singh Read more »

In this week’s episode of the BroadEYE Podcast, hosts Dr. Shawn Maloney and Dr. Carlos Quezada-Ruiz sit down with Dr. Wiley Chambers, recently retired Deputy Director of the Division of Ophthalmology at the U.S. Food and Drug Administration (FDA). With over 36 years at the FDA, Dr. Chambers offers a rare insider’s perspective on regulatory science, ophthalmic drug development, and the evolution of clinical trial oversight. This episode explores: Dr. Chambers also shares personal reflections on mentorship, scientific integrity, and his transition out of federal service after a distinguished career. About Our GuestDr. Wiley Chambers served as a lead ophthalmic reviewer …

Inside the FDA: Reflections from Dr. Wiley Chambers on Ophthalmic Drug Development Read more »

In this episode of the BroadEYE Podcast, we welcome inventor, researcher, and MacArthur Fellow Dr. Joshua Miele. Known for his pioneering work in accessible technology for blind users, Dr. Miele shares his journey from early advocacy to his role at Amazon’s Lab126, where he continues to develop tools that redefine independence and equity in the built and digital worlds. Explore Dr. Joshua Miele’s work, projects, and writings on his personal site, MieleLab, which highlights his innovations in accessible design and disability inclusion. You can visit it here: www.mielelab.com Joining as co-host is Victoria Nolan—a decorated Paralympian, accessibility advocate, and BroadEYE regular. With lived experience …

From Tactile Tech to Radical Inclusion: A Conversation with Dr. Joshua Miele Read more »

In this episode of the BroadEYE Podcast, host Sean Maloney is joined by guest co-host Dr. Carlos Quezada-Ruiz for a deep and inspiring conversation with Dr. Margaret Chang, one of the leading figures in retina research and innovation. From the start, Dr. Quezada-Ruiz sets the tone, describing Dr. Chang as not only a scientific leader but also a mentor, friend, and advocate for meaningful innovation. Their conversation ranges from early inspirations and pivotal career decisions to her ongoing efforts in bridging clinical research and real-world impact. Dr. Chang shares candid thoughts on what drives her work at the intersection …

Behind the Research: A Candid Conversation with Prof. Margaret Chang Read more »

In this episode of the BroadEye Podcast, hosts Shawn Maloney and Dr. Bruno Fernandes welcome Prof. Michel Michaelides, one of the most active clinical researchers in ophthalmology today. Prof. Michaelides leads a large inherited retinal disease clinic—seeing 30–40 children and adults each week—and splits her time between patient care, advanced imaging research, and steering more than ten ongoing clinical trials. Why This MattersInherited retinal diseases affect hundreds of thousands worldwide, and for most there is still no approved treatment. Over the past two years, we’ve seen multiple Phase 1/2 gene-therapy trials move into registrational studies, alongside novel antioxidant approaches …

Pushing the Frontiers of Inherited Retinal Disease Trials with Prof. Michel Michaelides Read more »

In this latest episode of the BroadEye podcast, hosts Shawn Maloney and Dr. Bruno Fernandes sit down with Dr. Arshad M. Khanani, MD, MA, FASRS, a pioneer in vitreoretinal gene-therapy trials and Managing Partner at Sierra Eye Associates. Dr. Khanani shares front-line insights into how genetic medicines are reshaping treatment for inherited and degenerative retinal diseases, highlighting both the promise and the practical challenges of bringing one-time therapies to patients. Why Gene Therapy Matters TodayRecent years have seen the first US approvals of in-vivo retinal gene therapies, beginning with voretigene neparvovec (Luxturna) for RPE65-mediated inherited retinal dystrophy in December 2017. …

Revolutionizing Retinal Gene Therapy with Dr. Arshad Khanani Read more »

In this episode of the BroadEYE Podcast, hosts Shawn Maloney and Dr. Bruno Fernandes sit down with Marc Workman, CEO of the World Blind Union (WBU), to explore global advocacy for blind and partially sighted individuals. From UN policy influence to AI’s transformative potential, Marc shares insights into WBU’s mission and his personal journey with retinitis pigmentosa. Listen on for the whole conversation! Meet Marc Workman Diagnosed with retinitis pigmentosa at age five, Marc became legally blind by ten. Now CEO of WBU, he leads global efforts to enhance accessibility and inclusion, drawing from his academic background in political …

Global Advocacy for the Blind with Marc Workman, CEO of World Blind Union Read more »

In this episode of the BroadEYE Podcast, hosts Shawn Maloney and Dr. Bruno Fernandes dive into a fascinating discussion with Dr. Peter Campochiaro, a clinician-scientist at Johns Hopkins’ Wilmer Eye Institute, about the potential of N-acetylcysteine (NAC) as a treatment for retinitis pigmentosa (RP). Dr. Campochiaro shares how his research journey began with unexpected findings in mouse models, revealing how excess oxygen in the retina—caused by the loss of rod photoreceptors in RP—leads to oxidative stress that damages surviving cone cells. This discovery paved the way for the NAC Attack clinical trial, a phase 3 study exploring whether NAC, …

NAC Attack Clinical Trial: Exploring Antioxidants and Retinitis Pigmentosa with Dr. Peter Campochiaro Read more »

In this episode, we sit down with Angela Bonfanti, the first female CEO and President of the Canadian National Institute for the Blind (CNIB). Angela shares her personal and professional journey, the challenges and opportunities of leading a 106-year-old organization, and her vision for improving accessibility and inclusion for individuals with vision loss in Canada. About the Guest Angela Bonfanti, the CEO and President of CNIB, is a trailblazer in the accessibility and inclusion space. With over 13 years of dedicated service at CNIB in various leadership roles, Angela became the organization’s leader in 2023, marking her 13th anniversary …

Leading with Vision: Angela Bonfanti’s Journey to Transforming Accessibility at CNIB Read more »

Dr. Carlos Quezada-Ruiz is a Vitreoretinal Surgeon and Assistant Professor of Ophthalmology at the Instituto de Oftalmologia Fundación Conde de Valenciana’s Retina Department in Mexico City. He also serves as the Senior Vice President of Clinical Research and Development and Therapeutic Area Head (Ophthalmology) at 4DMT, leading early- and late-stage clinical development teams focused on treating neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and geographic atrophy (GA). In addition to his active clinical practice, Dr. Quezada-Ruiz has spent the past decade as a Drug Developer, beginning at Genentech–Roche. There, he worked on the Ophthalmology management team as …

Revolutionizing Retinal Gene Therapy: A Conversation with Dr. Carlos Quezada-Ruiz Read more »